Register to get free articles
Want unlimited access? View Plans
Already have an account? Sign in
MHA has supported Initiate Consultancy in securing equity investment from Queen’s Park Equity to fund a management buyout and support the company’s next phase of growth.
Initiate Consultancy, which advises clients across the pharmaceutical, medical device and diagnostics sectors, said the investment would enable it to expand its global market access capabilities, scale service delivery and pursue complementary acquisitions.
The consultancy operates from offices in Northampton, London and Zug in Switzerland and provides market access and health economics and outcomes research (HEOR) services.
MHA’s corporate finance team acted as lead adviser to Initiate’s shareholders. The process attracted competing interest from potential partners in the UK, the US and Europe.
Andrew Mumford, chief executive of Initiate, said: “Partnering with QPE represents a pivotal moment for Initiate. Their deep sector expertise and operational support will enable us to further elevate our service offering and continue to expand our global footprint. Together, we are well positioned to deliver even more impactful access solutions for our clients.
“…The MHA team took the time to understand our goals as founders and worked closely with us to ensure we were fully informed at every stage, enabling us to make the right decisions along the way. Their proactive approach, responsiveness, and ability to anticipate potential challenges gave us complete reassurance throughout the journey.”
James Lawson, Corporate Finance partner at MHA, added: “Initiate leverages deep expertise in global payer regimes to help pharma and biotech clients demonstrate effectiveness and deliver groundbreaking therapies to patients who need them most. This partnership empowers Initiate’s exceptional leadership team to uphold its people-first culture while advancing its ambition to broaden service offerings and accelerate global expansion”
